Program Scope

This comprehensive certification program provides regulatory professionals with end-to-end knowledge of the global pharmaceutical regulatory landscape. The program covers the complete drug development lifecycle from discovery through post-approval lifecycle management, with specific focus on the regulatory requirements of the United States (FDA), European Union (EMA), and Japan (PMDA), as well as harmonization initiatives under the International Council for Harmonisation (ICH).

The program is structured to provide both foundational regulatory knowledge and advanced strategic capabilities across all major application types:

• Investigational New Drug (IND) applications for clinical trial authorization
• New Drug Applications (NDA) for innovative pharmaceuticals
• Abbreviated New Drug Applications (ANDA) for generic drugs
• Biologics License Applications (BLA) for biological products
• Orphan Drug Designation for rare disease treatments
• Special Programs including Accelerated Approval, Breakthrough Therapy, and Priority Review

The curriculum is designed for self-study, combining comprehensive theoretical instruction with practical real-world case studies and assessment tools. Each module builds upon the previous, creating a complete learning pathway from regulatory foundations to advanced submission strategies. The program incorporates the latest regulatory developments including GDUFA III, the FDA Drug Competition Action Plan, and evolving ICH guidelines, reflecting current regulatory thinking as of 2026.

Program Objectives

Upon successful completion of this certification program, participants will be able to:

• Understand the global regulatory framework governing pharmaceutical development, including the statutory and regulatory authorities in the US, EU, and Japan, and the harmonization initiatives under ICH that facilitate global drug development.
• Navigate the complete drug approval pathway from discovery through post-approval lifecycle management, identifying critical decision points and regulatory interactions at each stage of development.
• Prepare and submit complete regulatory applications including INDs, NDAs, ANDAs, and BLAs in the required eCTD format, with comprehensive understanding of each module’s requirements and the specific content expected by regulatory agencies.
• Design and interpret bioequivalence and clinical studies in accordance with ICH guidelines and regional requirements, applying appropriate statistical methods and understanding the regulatory expectations for demonstrating safety and efficacy.
• Apply patent certification strategies, exclusivity provisions, and intellectual property management techniques to optimize market entry and protect product investments.
• Engage effectively with regulatory agencies through formal interactions, meetings, and controlled correspondence, understanding the purpose and preparation required for each type of interaction.
• Manage post-approval changes and maintain compliance throughout the product lifecycle, including SUPAC requirements, annual reports, and postmarketing safety surveillance.
• Implement data integrity principles and quality metrics in drug development, ensuring compliance with CGMP requirements and maintaining inspection readiness.
• Navigate complex product development pathways including generics, biologics, biosimilars, and orphan drugs, understanding the unique regulatory considerations for each product type.
• Develop strategic regulatory approaches including risk assessment, timeline management, and resource allocation, enabling efficient and successful product development programs.

Target Audience

This certification program is designed for professionals working in or transitioning to roles involving pharmaceutical regulatory affairs. The content is appropriate for both early-career professionals seeking foundational knowledge and experienced professionals requiring updates on current regulatory requirements and best practices. The program is structured to accommodate learners at different experience levels, with foundational concepts clearly explained and advanced topics providing depth for experienced professionals.

Primary Target Audiences:

Regulatory Affairs Professionals

• Regulatory Affairs Associates, Managers, and Directors
• Regulatory Strategy Specialists and Submission Managers
• Labeling Specialists and Regulatory Project Managers
• Professionals seeking RAC certification preparation

Pharmaceutical Development and Formulation Scientists

• Formulation Scientists and Engineers
• Product Development Managers and Process Development Scientists
• Scale-up and Technical Transfer Specialists
• Professionals transitioning from R&D to regulatory roles

Quality Assurance/Quality Control Professionals

• Quality Assurance Managers and Directors
• Quality Control Managers and QA/QC Scientists
• Compliance Specialists and Auditors
• Professionals responsible for CGMP compliance

Clinical and Nonclinical Development Professionals

• Clinical Pharmacologists and Clinical Research Scientists
• Pharmacokineticists and Bioequivalence Study Managers
• Nonclinical Scientists in Pharmacology and Toxicology
• Clinical Research Associates and Monitors

CMC Specialists and Manufacturing Personnel

• CMC Regulatory Affairs Specialists
• Analytical Development Scientists and Stability Study Managers
• Bioprocess and Manufacturing Personnel
• Contract Manufacturing Organization personnel

Project Management Professionals

• Project Managers in Pharmaceutical Development
• Program Managers and Portfolio Managers
• Professionals coordinating cross-functional submission teams

Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) Personnel

• Business Development Professionals
• Study Directors and Project Managers
• Regulatory Affairs Specialists at service providers

Legal and Intellectual Property Professionals

• Patent Attorneys and Intellectual Property Counsel
• Regulatory Attorneys and Compliance Counsel
• Professionals advising on regulatory strategy

Level of Experience:

• Beginner: 0-2 years of experience in the pharmaceutical industry (foundational modules provide a comprehensive introduction)
• Intermediate: 2-5 years of experience (comprehensive modules build on existing knowledge)
• Advanced: 5+ years of experience (strategic workshops and case studies provide depth)

CERTIFICATION DETAILS

Certification Requirements

To earn the Certified Regulatory Affairs Professional (CRAP) certification, participants must successfully complete the following requirements:

Certificate of Completion

Learners who successfully complete all program requirements will receive a dated and traceable Certificate of Completion, providing verifiable evidence of their achievement for professional development records, employer qualification programs, and regulatory compliance documentation.

The certificate will include:

• Learner name
• Program title
• Date of completion
• Certificate identification number
• Issuing organization details
• Verification and traceability information

This certificate serves as formal recognition of successful completion of the Certified Regulatory Affairs Professional (CRAP) Certification Program.